Breast cancer is a highly heterogeneous disease, subdivided into three main groups: hormone receptor positive (HR+), human epidermal growth factor receptor 2 positive (HER2+) and triple negative breast cancer (TNBC). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.